3Adams Jr KF. Which β-blocker for heart failure? Editorial[J].Am Heart J, 2001,141:884-888.
4Bropht JN, Joseph L, Rouleaa JL.β-blockers in congestive heart failure - A Rayesiaa meta-analysis[J].Ann Intern Med,2001,134:550-560.
5Packer M, Antonopoulos GV , Berlin JA, et al .Comparative effect of carvedilol and metoprolol on left ventricular ejection fraction in heart failure: results of a meta-analysis[J].Am Heart J,2001,141:899-907.
6The Cardiac Insafficiency Bisoprolol study II (CIBIB-II): a randomized trial[J].Lancet, 1999,353:9-13.
7MERIT-HF Study Group.Effect of metoprolol CR/XL in chronic failure: metoprolol CR/XL. Randomized InterVention Trial in Congestive Heart Failure (MERIT- HF)[J].Lancet, 1999,253:2001-2007.
8Parcker M , Coats AJS, Fowler MB, et al. Effect of carVedilol on Survival in severe chronic heart failure[J]. N Engl J Med, 2001,344:1651-1658.
9Whorlow SL , Kram H .Meta-analysis of effect of β-blocker therapy on mortality in patients with New York Heart Association class IV chronic congestive heart failure[J].Am J Cardiol , 2000, 86:886-889.
7Satwani S,Dec GW,et al.β-adrenergic blockers in heart failure:Review of mechanisms of action and clinical outcomes[J].Journal of Cardiovascular Pharmacology and Therapeutics,2004,9(4),243～255.
8MERIT HF Study Group.Effect of metoprolol CR/XL in chronic heart failure:metoprolol CR/XL Randomized Inetrvention Trial in Congestive Heart Failure[J].Lancet,1999,253:2001～207.
9CIBIS-Ⅱ Investigators and Committees.The Cardiac Insuffciency Bissoporolol Study Ⅱ(CIBIS Ⅱ):a randomizde trial[J].Lancet,1999,353:9～13.
10Ellison K E,Gandhi G.Optimising the use of β-adrenoceptor antagonists in coronary artery disease[J].Drugs,2005,65(6),787～797.
